Physician profile
Malcolm D Paul
NPI 1124108253
$97,380.53
in general payments reported to CMS, 2019-2025
14 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29K · 2022: $36K · 2023: $31K · 2024: $1,271 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Food and Beverage: $1,421 · Debt Forgiveness: $1,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,000.00 |
| Food and Beverage | $1,421.33 |
| Debt Forgiveness | $1,231.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Canary Medical USA LLC | $60,259.20 | 2022-2023 | |
| Acelrx Pharmaceuticals, INC. | $31,555.83 | 2021-2022 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $2,000.00 | 2021 | |
| Johnson & Johnson Health Care Systems INC. | $1,231.90 | 2024 | |
| Mentor Worldwide LLC | $779.96 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $387.56 | 2022 | |
| Integra Lifesciences Corporation | $272.15 | 2023 | Integra, Durasorb Monofilament Mesh, Integra Dermal Regeneration Template |
| Motiva USA, LLC | $219.90 | 2025 | |
| Abbvie INC. | $194.42 | 2023-2024 | |
| Sientra, INC. | $169.84 | 2021 | |
| Smith+Nephew, INC. | $132.06 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $96.66 | 2025 | |
| Davol INC. | $60.02 | 2022 | |
| Galderma Laboratories, L.P. | $21.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malcolm Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.